Skip to content

Effectiveness of acupuncture for gastrointestinal dysfunction in Parkinson's disease

A clinical randomized controlled study of acupuncture for Parkinson's gastrointestinal dysfunction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14324113
Enrollment
88
Registered
2024-03-14
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal dysfunction in patients with Parkinson's disease Digestive System

Interventions

The random allocation sequence will be generated using a random number table method by a statistician not involved in the trial. Allocation sequences will be concealed in sequentially numbered, sealed

Sponsors

Beijing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Idiopathic PD diagnosis 2. Gastrointestinal dysfunction meeting Rome IV FGIDs criteria 3. Ability to provide written informed consent 4. Men or women aged 40 to 80 years 5. Liver function, kidney function, blood routine, urine routine, and stool routine are all normal

Exclusion criteria

Exclusion criteria: 1. Gastrointestinal dysfunction caused by other diseases 2. Severe heart, liver, kidney, or other organ dysfunction 3. Have been taking gastrointestinal motility drugs and laxative drugs for a long time 4. Severe cognitive impairment and language impairment who cannot cooperate with the rating 5. Inability to adhere to the study protocol as determined by the investigator

Design outcomes

Primary

MeasureTime frame
1. Gastrointestinal dysfunction is measured using the electrogastrogram at baseline and 4 weeks 2. Blood Serum Index is measured using radioimmunoassay at baseline and 4 weeks 3. Gastrointestinal dysfunction is measured using the Rome IV functional gastrointestinal disorders (FGID) criteria at baseline and 4 weeks

Secondary

MeasureTime frame
1. Stool analysis by 16S-rRNA high throughput sequencing at baseline and 4 weeks 2. The extent of Parkinson's disease is measured using the Unified Parkinson's disease rating scale (UPDRS) and the Hoehn–Yahr Rating Scale at baseline, 4, 12 and 24 weeks

Countries

China

Contacts

Public ContactPanlin Cen
annasum09@gmail.com+86 (0)13671250590

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026